Population pharmacokinetic study in children with vascular anomalies: body weight as a key variable in predicting the initial dose and dosing frequency of sirolimus
Sirolimus
Regimen
Trough Concentration
DOI:
10.3389/fphar.2024.1457614
Publication Date:
2024-09-24T04:43:03Z
AUTHORS (9)
ABSTRACT
The main challenges faced when using sirolimus in children with vascular anomalies (VAs) still include significant pharmacokinetic (PK) variability, uncertainty the target concentration range, as well inconsistencies initial dosing and frequency. aim of this study is to establish a new population (PPK) model for VAs guide individualized use sirolimus.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (59)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....